Home›Stock Screener›Ambalal Sarabhai Enterprises›Quarterly Results

Ambalal Sarabhai Enterprises Quarterly Results

Latest Quarter Net Profit
₹7 Cr
QMar 2026
Quarterly Results

Ambalal Sarabhai Enterprises quarterly results. In Mar 2026, Ambalal Sarabhai Enterprises (AMBALALSA) reported revenue ₹69 Cr and net profit ₹7 Cr — revenue +4.5% YoY. For annual financials, live price and key ratios, visit AMBALALSA screener.

AMBALALSA Quarterly Results — Revenue, Profit & EPS Highlights

Ambalal Sarabhai Enterprises latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review AMBALALSA earnings valuation to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹69 Cr in Mar 2026 (+50.0% vs Jun 2026, +4.5% vs Mar 2025)
  • Net Profit of ₹7 Cr in Mar 2026 (+75.0% vs Jun 2026)
  • EBITDA of ₹9 Cr in Mar 2026 (+28.6% vs Jun 2026)
  • Operating Margin of 9.0% in Mar 2026 (-1.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.85 in Mar 2026 (+63.5% vs Jun 2026)

Ambalal Sarabhai Enterprises Quarterly Results — Revenue, EBITDA, Net Profit & EPS

AMBALALSA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 69 46 46 66 49 50.0% 4.5%
Net Profit (₹ Cr) 7 4 -1 0 8 - -
EBITDA (₹ Cr) 9 7 2 0 10 - -
EPS (₹) 0.85 0.52 -0.07 -0.04 1.07 - -
Operating Margin (%) 9.0% 10.0% 1.0% -3.0% 4.0% - -

AMBALALSA Share Price Trend — 1-Year Movement Across Quarterly Results

Ambalal Sarabhai Enterprises 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check AMBALALSA market value to track the company's total market size over time.

Profitability Ratios

Profit Margin 10.1%
EBITDA Margin 13.0%
Operating Margin 9.0%
ROE (Annual) 17.7%

Balance Sheet Highlights

Total Assets ₹281 Cr
Total Equity ₹158 Cr
Current Assets ₹125 Cr
Current Liabilities ₹24 Cr

Cash Flow Analysis

Operating Cash Flow ₹13 Cr
Investing Cash Flow ₹-10 Cr
Financing Cash Flow ₹-2 Cr
Net Cash Flow ₹1 Cr

Current Market Data

Current Price ₹46.32
Exchange NSE
Last Updated Aug 19, 2026

Revenue Trend (₹ Cr)

Mar 2025 66
Sept 2025 46
Jun 2026 46
Mar 2026 69

Net Profit Trend (₹ Cr)

Mar 2025 0
Sept 2025 -1
Jun 2026 4
Mar 2026 7

Operating Margin Trend (%)

Mar 2025 -3.0%
Sept 2025 1.0%
Jun 2026 10.0%
Mar 2026 9.0%

AMBALALSA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Ambalal Sarabhai Enterprises latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1804.1 15,018 2,710 -5.6% - 18.0% 159.7
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9550.0 2,986 751 -5.0% - 25.2% 337.3
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1159.5 7,569 1,341 -4.3% - 17.7% 91.7
Laurus Labs
Mar 2026 		₹109,629.35 Cr 2050.0 1,823 282 -10.5% - 15.5% 396.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores